NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, joined the broad-market Russell 3000® Index as well as the Russell 2000® , Russell Global and Russell Microcap® on June 27, 2014.
Help employers find you! Check out all the jobs and post your resume.
